Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Beijing Leadman Biochemistry Dividend Announcement
• Beijing Leadman Biochemistry announced a annually dividend of ¥0.01 per ordinary share which will be made payable on 2024-05-17. Ex dividend date: 2024-05-17
• Beijing Leadman Biochemistry annual dividend for 2024 was ¥0.01
• Beijing Leadman Biochemistry's trailing twelve-month (TTM) dividend yield is 0.19%
• Beijing Leadman Biochemistry's payout ratio for the trailing twelve months (TTM) is -148.20%
Beijing Leadman Biochemistry Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-17 | ¥0.01 | annually | 2024-05-17 |
2022-05-19 | ¥0.02 | annually | 2022-05-19 |
2020-06-08 | ¥0.01 | annually | 2020-06-08 |
2018-07-06 | ¥0.03 | annually | 2018-07-06 |
2017-06-15 | ¥0.01 | annually | 2017-06-15 |
2016-06-16 | ¥0.06 | annually | |
2015-05-27 | ¥0.15 | annually | |
2014-06-06 | ¥0.14 | annually | |
2013-06-13 | ¥0.13 | annually | |
2012-05-22 | ¥0.10 | annually |
Beijing Leadman Biochemistry Dividend per year
Beijing Leadman Biochemistry Dividend growth
Beijing Leadman Biochemistry Dividend Yield
Beijing Leadman Biochemistry current trailing twelve-month (TTM) dividend yield is 0.19%. Interested in purchasing Beijing Leadman Biochemistry stock? Use our calculator to estimate your expected dividend yield:
Beijing Leadman Biochemistry Financial Ratios
Beijing Leadman Biochemistry Dividend FAQ
Other factors to consider when evaluating Beijing Leadman Biochemistry as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Beijing Leadman Biochemistry stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Beijing Leadman Biochemistry's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Beijing Leadman Biochemistry publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Beijing Leadman Biochemistry distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Beijing Leadman Biochemistry are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Beijing Leadman Biochemistry sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Beijing Leadman Biochemistry distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Beijing Leadman Biochemistry declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Beijing Leadman Biochemistry's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Beijing Leadman Biochemistry's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.